136 related articles for article (PubMed ID: 7346797)
1. CEA positivity in tissue and sera of patients with benign breast lesions.
Wittekind C; Von Kleist S; Sandritter W
Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
Wittekind C; von Kleist S; Sandritter W
Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
[TBL] [Abstract][Full Text] [Related]
3. Estrogen staining in breast carcinoma by PAP methods compared to CEA and ferritin staining.
Osamu K; Takashi M; Yohichi T; Yasuo U; Tetsuro Y; Yoshiro F; Toshio T
Cancer Detect Prev; 1987; 10(1-2):113-20. PubMed ID: 2436774
[TBL] [Abstract][Full Text] [Related]
4. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
[TBL] [Abstract][Full Text] [Related]
5. Immunoperoxidase detection of carcinoembryonic antigen in fine needle aspirates of breast carcinoma. Correlation with studies in tissue sections.
Murthy L; Kapila K; Verma K
Acta Cytol; 1988; 32(1):60-2. PubMed ID: 3276079
[TBL] [Abstract][Full Text] [Related]
6. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoembryonic antigen in benign and malignant lesions of the breast].
Iannotti G; Pagnano MA; Campanile M; Catalano D; Paladini A
Arch Ostet Ginecol; 1981; 86(5-6):211-6. PubMed ID: 7349744
[No Abstract] [Full Text] [Related]
9. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
10. The biological and clinical significance of tumor markers in tissue extracts.
Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
12. CEA and HMFG in hyperplastic and malignant lesions of the breast.
De Potter CR; Beghin C; Praet MM; Pauwels CF; Roels HJ
Pathol Res Pract; 1988 Jun; 183(3):271-6. PubMed ID: 2843840
[TBL] [Abstract][Full Text] [Related]
13. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
15. Immunoperoxidase localization of lactalbumin in malignant breast neoplasms.
Clayton F; Ordóñez NG; Hanssen GM; Hanssen H
Arch Pathol Lab Med; 1982 Jun; 106(6):268-70. PubMed ID: 6284085
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
17. Feulgen DNA cytophotometry in histologic sections of mammary neoplasms.
Berryman I; Sterrett GF; Papadimitriou JM
Anal Quant Cytol; 1984 Mar; 6(1):19-23. PubMed ID: 6732070
[TBL] [Abstract][Full Text] [Related]
18. [Comparative immunohistological studies of the localization of the carcinoembryonic antigen in benign and malignant breast tissue].
Wittekind C; von Kleist S; Sandritter W
Acta Histochem Suppl; 1982; 25():83-7. PubMed ID: 6806865
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
Nesland JM; Lunde S; Holm R; Johannessen JV
Histol Histopathol; 1987 Jan; 2(1):73-7. PubMed ID: 2980706
[TBL] [Abstract][Full Text] [Related]
20. [MSA--a new sensitive tumor marker in breast carcinoma].
Zahm DM; Greinke C; Nöschel H
Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
